Efficacy of Ganaton (itopride hydrochloride) use in the treatment of patients with functional dyspepsia
- Authors: Ivashkin VT1, Sheptulin AA1, Trukhmanov AS1
-
Affiliations:
- Issue: No 13 (2009)
- Pages: 50-54
- Section: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/277443
- ID: 277443
Cite item
Full Text
Abstract
We assessed the Ganaton (itopride hydrochloride) efficacy in the treatment of 509 patients with functional dyspepsia (FD). We estimated the symptoms severity according to a points system. It noted the frequent combination of PD with heartburn, nausea, bloating, and bowel function disorders. Ganaton administration at a dose of 150 mg daily for 4 weeks contributed to the complete disappearance of complaints in 46.6% of patients and significant decrease in its severity in 47.8% of patients. The drug administration was well tolerated; serious side effects were not observed.
References
- Ивашкин В.Т., Шептулин А.А., Баранская Е.К. и др. Рекомендации по обследованию и лечению больных с синдромом диспепсии. М., 2000. С. 1-7.
- Brogden R, Carmine A, Heel R, et al. Domperidone. A review of its pharmacological activity, pharmacokinetics and therapeutic efficacy in the symptomatic treatment of chronic dyspepsia and as antiemetic. Drugs1982;24:360-400.
- Corsetti M, Tack J. Mechnisms of functional dyspepsia and its relation to IBS // Irritable bowel syndrome (Ed. Camilleri M., Spiller M.C.). London 2002:117-26.
- Ganaton Post Marketing Surveillance Study Group. Gastroenterology Today 2004;8:1-8.
- Holtmann G, Talley NJ, Liebregts T, et al. A placebo-controlled trial of itopride in functional dyspepsia. N Engl J Med 2006;354:832-40.
- Inoue K, Sanada Y, Fijimura J, et al. Clinical effect of itopride hydrochloride on the digestive symptoms of chronic gastritis with reflux esophagitis. Clinical Medicine 1999;15:1803-08.
- Karamanolis G, Tack J. Promotility medications - now and in the future. Dig Dis 2006;24:297-307.
- Moayyedi P, Soo S, Deeks J, et al. Systemic review: Antacids, H2-receptor antagonists, prokinetiks, bismuth and sucralfate therapy for non-ulcer dyspepsia. Aliment Pharmacol Ther 2003;17:1215-27.
- Sawant P, Das HS, Desai N, et al. Comparative evaluation of the efficacy and tolerability of itopride hydrochloride and domperidone in patients with non-ulcer dyspepsia. JAPI 2004;52:626-28.
- Smout AJPM, Akkermans LMA. Normal and disturbed motility of the gastrointestinal tract. Wrightson Biomedical Publishing Ltd. - Petersfield.
- Tack J, Talley NJ, Camilleri M, et al. Functional gastroduodenal disorders. Gastroenterology 2006;130:1466-79.
- http://www.pharmateca.ru/cgi-bin/statyi.pl?sid=2373&mid=1085056570&magid=177
Supplementary files
